Potential applications of carbomer in oral mucoadhesive controlled drug delivery system: A review

Drug Development and Industrial Pharmacy

Volumn 26, Issue 9, 2000, Pages 913-924

  Singla, Anil K ^a   Chawla, Manish ^a   Singh, Amarjit ^b  

^a PANJAB UNIVERSITY   (India)

^b Panacea Biotec Ltd   (India)

Author keywords

Carbomer; CDDS; Drug release mechanism; Mucoadhesion; Oral peptide delivery

Indexed keywords

AMINOPHYLLINE; BENZOCAINE; BENZYDAMINE; CAPTOPRIL; CARBOMER; CHLORHEXIDINE; CHLORPHENIRAMINE MALEATE; CLOTRIMAZOLE; DICLOFENAC; ETRETIN; FLUORIDE SODIUM; HYDROCHLOROTHIAZIDE; HYDROCORTISONE; HYDROCORTISONE SODIUM SUCCINATE; INDOMETACIN; LIDOCAINE; METRONIDAZOLE; MICONAZOLE NITRATE; MUCIN; PEPTIDE DERIVATIVE; PROPRANOLOL; SULPIRIDE; TENOXICAM; UNINDEXED DRUG; VERAPAMIL;

ADHESION; CHELATION; CONTROLLED RELEASE FORMULATION; DRUG DELIVERY SYSTEM; DRUG SOLUBILITY; PHYSICAL CHEMISTRY; REVIEW;

ACRYLIC RESINS; ADHESIVES; ADMINISTRATION, BUCCAL; CHEMISTRY, PHARMACEUTICAL; CHEMISTRY, PHYSICAL; DELAYED-ACTION PREPARATIONS; DRUG DELIVERY SYSTEMS;

EID: 0033928654     PISSN: 03639045     EISSN: None     Source Type: Journal    
DOI: 10.1081/DDC-100101318     Document Type: Review

References (109)

1. B. F. Goodrich, The Science of Rheology: Pharmaceutically Applied, technical note, Brecksville, OH, 1992.
2. A. Wade and P. J. Weller, Eds., Handbook of Pharmaceutical Excipients, Pharmaceutical Press, London, 1994, p. 71.
3. T. Nakanishi, F. Kaiho, and M. Hayashi, Chem. Pharm. Bull., 46, 171 (1998).
4. C. A. Dittmar, Drug Cosmet. Ind., 110, 52 (1972).
5. C. A. Dittmar, Drug Cosmet. Ind., 110, 127 (1972).
6. N. W. Taylor and E. B. Bagley, J. Appl. Polym. Sci., 18, 2747 (1974).
7. N. W. Taylor and E. B. Bagley, J. Polym. Sci., 13, 1133 (1975).
8. B. F. Goodrich, Application Guide for Personal Care Products, technical literature, Brecksville, OH, 1995.
9. A. J. Grossman, R. C. Batterman, and P. Leifer, J. Am. Geriatr. Soc., 5, 187 (1957).
10. G. P. Child, T. Brisk, M. Larson, S. Goff, R. L. Markus, and C. Clancy, Fed. Proc., 14, 326 (1955).
11. J. D. Smart, I. W. Kellaway, and H. E. C. Worthington, J. Pharm. Pharmacol., 36, 295 (1984).
12. S. Sharma, S. G. M. J. Lobo, and J. D. Smart, J. Pharm. Pharmacol., 42, 129P (1990).
13. E. A. Hosny, Int. J. Pharm., 133, 149 (1996).
14. S. N. Foster, J. P. Pearson, D. A. Hutton, A. Allen, and P. W. Dettmar, Clin. Sci. (Colch), 87, 719 (1994).
15. E. A. Hosny and M. A. Al-Meshal, Drug Dev. Ind. Pharm., 20, 2715 (1994).
16. I. Bjarnason, P. Smethurst, A. J. Levi, I. S. Menzies, and T. J. Peters, Scand. J. Gastroenterol., 26, 685 (1991).
17. M. Ishida, Y. Machida, N. Nambu, and T. Nagai, Chem. Pharm. Bull., 29, 810 (1981).
18. H. L. Leußen, C.-M. Lehr, C.-O. Rentel, A. B. J. Noach, A. G. de Boer, J. C. Verhoef, and H. E. Junginger, J. Controlled Release, 29, 329 (1994).
19. C.-M. Lehr, J. A. Bouwstra, W. Kok, A. G. de Boer, J. J. Tukker, J. C. Verhoef, D. D. Breimer, and H. E. Junginger, J. Pharm. Pharmacol., 4, 402 (1992).
20. E. A. Hosny and M. A. Al-Meshal, Die Pharm. Ind., 56, 71 (1994).
21. B. F. Goodrich, Controlled Release Tablets and Capsules, Bulletin no. 17, Brecksville, OH, 1995.
22. G. Levy and W. J. Jusko, J. Pharm. Sci., 54, 219 (1965).
23. R. R. Hewitt and G. Levy, J. Pharm. Sci., 60, 784 (1971).
24. J. J. Ashley and G. Levy, J. Pharm. Sci., 62, 688 (1973).
25. L. L. Huang and J. B. Schwartz, Drug Dev. Ind. Pharm., 21, 1487 (1995).
26. H. P. Brown, U.S. Pat. 2,798,053 (1957).
27. J. R. Robinson, in Bioadhesion: Possibilities and Future Trends (R. Gurny and H. E. Junginger, Eds.), Wissenschaftliche Verlagsgesellschaft, Stuttgart, 1989, p. 13.
28. J. L. Kanig and P. Manago-Ulgado, J. Oral Ther. Pharmacol., 1, 413 (1965).
29. H. P. Merkle, R. Anders, J. Sandow, and W. Schurr, Proc. Int. Symp. Controlled Release Bioact. Mater., 12, 85 (1985).
30. S. P. Vyas and C. P. Jain, J. Microencapsulation, 9, 457 (1992).
31. M. R. Jimenez-Castellanos, H. Zia, and C. T. Rhodes, Int. J. Pharm., 105, 65 (1994).
32. L. Illum, H. Jorgensen, H. Bisgaard, O. Krogsgaard, and N. Rossing, Int. J. Pharm., 39, 189 (1987).
33. K. Morimoto, K. Morisaka, and A. Kamada, J. Pharm. Pharmacol., 37, 134 (1985).
34. H. Critchley, S. S. Davis, N. F. Farraj, and L. Illum, J. Pharm. Pharmacol., 46, 651 (1994).
35. T. Nagai and Y. Machida, Pharm. Int., 6, 196 (1985).
36. C.-M. Lehr, V. H. Lee, and Y. H. Lee, Invest. Opthalmol. Vis. Sci., 35, 2809 (1994).
37. M. F. Saettone, D. Monti, M. T. Torracca, and P. Chetoni, J. Ocul. Pharmacol., 10, 83 (1994).
38. M. Dittgen, S. Oestereich, and D. Eckhardt, Pharmazie, 46, 716 (1991).
39. E. A. Hosny and A. A. Al-Angary, Int. J. Pharm., 113, 209 (1995).
40. E. A. Hosny, M. N. Esmail, and A. S. El-Gorashi, Int. J. Pharm., 117, 147 (1995).
41. A. D. Woolfson, D. F. McCafferty, P. A. McCarron, and J. H. Price, J. Controlled Release, 35, 45 (1995).
42. R. J. Good, J. Adhesion, 8, 1 (1976).
43. M. A. Longer, H. S. Ch'ng, and J. R. Robinson, J. Pharm. Sci., 74, 406 (1985).
44. N. A. Peppas and P. A. Buri, J. Controlled Release, 2, 257 (1985).
45. G. Ponchel, F. Touchard, D. Duchene, and N. A. Peppas, J. Controlled Release, 5, 129 (1987).
46. A. S. Bouckaert, R. A. Lefebvre, F. Colardyn, and J. P. Remon, Eur. J. Clin. Pharmacol., 41, 331 (1993).
47. A. S. Bouckaert, L. Vakaet, and J. P. Remon, Int. J. Pharm., 130, 257 (1996).
48. N. Kohri, I. Naasani, K. Iseki, and K. Miyazaki, J. Pharm. Pharmacol., 48, 371 (1996).
49. S. H. Neau, M. Y. Chow, and M. J. Durrani, Int. J. Pharm., 131, 47 (1996).
50. S. M. Safwat, Eur. J. Pharm. Biopharm., 40, 321 (1994).
51. D. Harris, J. T. Fell, D. C. Taylor, J. Lynch, and H. L. Sharma, Int. J. Pharm., 56, 97 (1989).
52. S. Burgalassi, L. Panichi, M. F. Saettone, J. Jacobsen, and M. R. Rassing, Int. J. Pharm., 133, 1 (1996).
53. M. K. Nair and Y. W. Chien, Drug Dev. Ind. Pharm., 22, 243 (1996).
54. B. Taylan, Y. Capan, O. Guven, S. Kes, and A. A. Hincal, J. Controlled Release, 38, 11 (1996).
55. P. Bottenberg, R. Cleymaet, C. De Muynck, J. P. Remon, D. Coomans, Y. Michotte, and D. Slop, J. Pharm. Pharmacol., 43, 457 (1991).
56. P. Minghetti, A. Colombo, L. Montanari, G. M. Goeta, and F. Gombos, Int. J. Pharm., 169, 195 (1998).
57. G. Ponchel, F. Touchard, D. Wouessidjewe, D. Duchene, and N. A. Peppas, Int. J. Pharm., 38, 65 (1987).
58. W.-G. Chen and G. C.-C. Hwang, Int. J. Pharm., 82, 61 (1992).
59. C. Prudat-Christaens, P. Arnaud, P. Allain, and J. C. Chaumeil, Int. J. Pharm., 141, 109 (1996).
60. J. L. Fabregas and N. Garcia, Drug Dev. Ind. Pharm., 21, 1689 (1995).
61. A. E. Collins and P. B. Deasy, J. Pharm. Sci., 79, 116 (1990).
62. P. Minghetti, B. Pacchetti, L. Montanari, C. Ronchi, and F. Berlati, Boll. Chim. Farm., 136, 543 (1997).
63. R. S. Matharu and N. M. Sanghavi, Drug Dev. Ind. Pharm., 18, 1567 (1992).
64. A. Gupta, S. Garg, and R. K. Khar, Indian Drugs, 30, 152 (1992).
65. G. M. Khan and Z. Jiabi, J. Controlled Release, 54, 185 (1998).
66. F. Lejoyeux, G. Ponchel, D. Wouessidjewe, N. A. Peppas, and D. Duchene, Drug Dev. Ind. Pharm., 15, 2037 (1989).
67. K. V. Ranga Rao, A. Ben-Amor, and P. Buri, STP Pharma, 5, 899 (1989).
68. D. L. French and J. W. Mauger, Pharm. Res., 10, 1285 (1993).
69. M. Rillosi and G. Buckton, Pharm. Res., 12, 669 (1995).
70. L. Achar and N. A. Peppas, J. Controlled Release, 31, 271 (1994).
71. S. A. Mortazavi, Int. J. Pharm., 173, 124 (1995).
72. K. Hamaguchi and E. P. Geiduschek, J. Am. Chem. Soc., 84, 1329 (1962).
73. Y. Hatefi and W. G. Hanstein, Proc. Natl. Acad. Sci. USA, 62, 1129 (1969).
74. J. M. Gu, J. R. Robinson, and S. H. S. Leung, Crit. Rev. Ther. Drug Carrier Sys., 5, 21 (1988).
75. F. Madsen, K. Eberth, and J. D. Smart, J. Controlled Release, 50, 167 (1998).
76. L. J. Kerr, I. W. Kellaway, J. D. Lewis, D. R. Kelly, and G. D. Parr, Proc. Int. Symp. Controlled Release Bioact. Mater., 16, 400 (1989).
77. S. A. Mortazavi, B. G. Carpenter, and J. D. Smart, J. Pharm. Pharmacol. (suppl.), 45, 1141 (1993).
78. K. V. Ranga Rao and P. Buri, Int. J. Pharm., 52, 265 (1989).
79. S. A. Mortazavi and J. D. Smart, J. Controlled Release, 25, 197 (1993).
80. I. Malley, J. Bardon, M. Rollet, J. L. Taverdet, and J. M. Vergnaud, Drug Dev. Ind. Pharm., 13, 67 (1987).
81. B. Perez-Marcos, R. Iglesias, J. L. Gomez-Amoza, R. Martinez-Pacheco, C. Sauto, and A. Concheiro, J. Controlled Release, 17, 267 (1991).
82. B. Perez-Marcos, C. Gutierrez, J. L. Gomez-Amoza, R. Martinez-Pacheco, C. Sauto, and A. Concheiro, Int. J. Pharm., 67, 113 (1991).
83. V. R. Goskonda, I. K. Reddy, M. J. Durrani, W. Wilber, and M. A. Khan, J. Controlled Release, 54, 87 (1998).
84. B. Perez-Marcos, J. L. Ford, D. J. Armstrong, P. N. C. Elliott, C. Rostron, and J. E. Hogan, J. Pharm. Sci., 85, 330 (1996).
85. B. Perez-Marcos, J. L. Ford, D. J. Armstrong, P. N. C. Elliott, C. Rostron, and J. E. Hogan, Int. J. Pharm., 111, 251 (1994).
86. K. Satoh, K. Takayama, Y. Machida, Y. Suzuki, M. Nakagaki, and T. Nagai, Chem. Pharm. Bull., 37, 1366 (1989).
87. K. Satoh, K. Takayama, Y. Machida, Y. Suzuki, and T. Nagai. Chem. Pharm. Bull., 37, 1642 (1989).
88. M. J. Tobyn, J. R. Johnson, and P. W. Dettmar, Eur. J. Pharm. Biopharm., 42, 331 (1996).
89. N. Unlu, A. Ludwig, M. van-Ooteghem, and A. A. Hincal, Pharm. Acta Helv., 67, 5 (1992).
90. S. Y. Lin, G. L. Amidon, N. D. Weiner, and A. H. Goldberg. Pharm. Res., 10, 411 (1993).
91. J. D. Smart, Drug Dev. Ind. Pharm., 18, 223 (1992).
92. S. Senel, Y. Capan, M. F., Sargon, C. B. Giray, and A. A. Hincal, Int. J. Pharm., 170, 239 (1998).
93. N. Realdon, E. Ragazzi, M. D. Zotto, and G. D. Fini, Drug Dev. Ind. Pharm., 24, 337 (1998).
94. M. N. Mutimer, C. Riffkin, J. A. Hill, M. E. Glickman, and D. N. Cyr, J. Am. Pharm. Assoc. Sci. Ed., 45, 212 (1956).
95. C.-M. Lehr, Crit. Rev. Ther. Drug Carrier Sys., 11, 119 (1994).
96. Bernkop-Schnurch, Sci. Pharm, 65, 61 (1997).
97. C.-M. Lehr, J. A. Bouwstra, A. G. de Boer, J. C. Verhoef, D. D. Breimer, and H. E. Junginger, in Drug Targeting and Delivery: Concepts in Dosage Form Design (H. E. Junginger, Ed.), Ellis Harwood, London, 1992, p. 92.
98. J. P. Bai, L. L. Chang, and J. H. Guo, J. Pharm. Sci., 84, 1291 (1995).
99. H. L. Leussen, B. J. de Leeuw, D. Perard, C.-M. Lehr, and H. E. Junginger, Eur. J. Pharm. Sci., 4, 117 (1996).
100. H. L. Leussen, J. C. Verhoef, G. Borchard, C.-M. Lehr, and H. E. Junginger, Pharm. Res., 12, 1293 (1995).
101. B. Kriwet and T. Kissel, Int. J. Pharm., 127, 135 (1996).
102. H. D. Bartunik, L. J. Summers, and H. H. Bartsch, J. Mol. Biol., 210, 813 (1989).
103. P. Artursson and C. Magnusson, J. Pharm. Sci., 79, 595 (1990).
104. J. Woodley and S. Kenworthy, Proc. Int. Symp. Controlled Release Bioact. Mater., 24 (1997).
105. J. P. Bai, L. L. Chang, and J. H. Guo, J. Pharm. Pharmacol., 48, 17 (1996).
106. T. Nakanishi, F. Kaicho, and M. Hayashi, Int. J. Pharm., 171, 177 (1998).
107. H. L. Leußen, C.-O. Rentel, A. F. Kotze, C.-M. Lehr, A. G. de Boer, J. C. Verhoef, and H. E. Junginger, J. Controlled Release, 45, 15 (1997).
108. E. Illan, S. Amselem, M. Weisspapir, J. Schwarz, A. Yogev, E. Zawoznik, and D. Friedman, Pharm. Res., 13, 1083 (1996).
109. H. L. Leußen, B. J. de Leeuw, M. W. E. Langemeyer, A. G. de Boer, J. C. Verhoef, and H. E. Junginger. Pharm. Res., 13, 1668 (1996).